These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2358716

  • 21. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 22. Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS).
    Maeda M, Kachi H, Mori S.
    J Dermatol Sci; 1996 Mar; 11(3):223-7. PubMed ID: 8785174
    [Abstract] [Full Text] [Related]

  • 23. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R, Murata M, Takayama N, Tokuhira M, Kizaki M, Okamoto S, Kawai Y, Watanabe K, Murakami H, Kikuchi M, Nakamura S, Ikeda Y.
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [Abstract] [Full Text] [Related]

  • 24. [Influence of thoracotomy and pulmonary surgery on coagulation and fibrinolysis in the intra and postoperative period--experimental and clinical study].
    Sembo J.
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):199-209. PubMed ID: 2747605
    [Abstract] [Full Text] [Related]

  • 25. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T, Gando S, Murata A, Kushimoto S, Saitoh D, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Ikeda T, Ishhikura H, Ueyama M, Ogura Y, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group.
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [Abstract] [Full Text] [Related]

  • 26. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma.
    Gadducci A, Baicchi U, Marrai R, Del Bravo B, Fosella PV, Facchini V.
    Gynecol Oncol; 1994 Jun; 53(3):352-6. PubMed ID: 8206409
    [Abstract] [Full Text] [Related]

  • 27. [Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease].
    Shimazu C, Fukuda T, Yugeta N, Yasuda K, Wakasugi K, Tahara C, Miyajima Y, Kazama M.
    Rinsho Byori; 1991 Mar; 39(3):295-301. PubMed ID: 1828841
    [Abstract] [Full Text] [Related]

  • 28. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].
    Mutoh S, Teh A, Shimoji Y, Nishi N, Saitoh M, Maki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2049-58. PubMed ID: 3878385
    [Abstract] [Full Text] [Related]

  • 29. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT, Blamey SL, Lowe GD, Carter DC, Forbes CD.
    Thromb Haemost; 1985 Apr 22; 53(2):235-8. PubMed ID: 2410995
    [Abstract] [Full Text] [Related]

  • 30. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y.
    Fukuoka Igaku Zasshi; 1991 Nov 22; 82(11):576-85. PubMed ID: 1774013
    [Abstract] [Full Text] [Related]

  • 31. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
    Bärtsch P, Haeberli A, Straub PW.
    Thromb Haemost; 1990 Jun 28; 63(3):430-4. PubMed ID: 2402746
    [Abstract] [Full Text] [Related]

  • 32. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G.
    Infusionsther Transfusionsmed; 1994 Aug 28; 21(4):244-50. PubMed ID: 7950289
    [Abstract] [Full Text] [Related]

  • 33. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E.
    Rinsho Byori; 1991 Mar 28; 39(3):309-14. PubMed ID: 1828842
    [Abstract] [Full Text] [Related]

  • 34. [Study on dynamic changes in coagulability and von Willebrand factor and its correlation with prognosis of cardiopulmonary resuscitation].
    Zhou JX, Qi LM, Cheng RN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec 28; 21(12):734-7. PubMed ID: 20042140
    [Abstract] [Full Text] [Related]

  • 35. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
    Widström O, Kockum C, Nilsson BS.
    Scand J Respir Dis; 1978 Aug 28; 59(4):210-5. PubMed ID: 694476
    [Abstract] [Full Text] [Related]

  • 36. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T.
    Hokkaido Igaku Zasshi; 1982 May 28; 57(3):351-63. PubMed ID: 6957368
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.